By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences has filed for an initial public offering in the US, seeking to raise up to $200 million.

The Menlo Park, Calif.-based maker of a single-molecule, real-time sequencing (SMRT) technology platform, today filed a preliminary prospectus with the US Securities and Exchange Commission for the offering. It has not said how many shares that it intends to offer or when it anticipates the IPO will become effective

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.